Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
Interleukin 2 (IL-2) plays a fundamental role in both immune activation and tolerance and has revolutionized the field of cancer immunotherapy since its discovery. The ability of IL-2 to mediate tumor regression in preclinical and clinical settings led to FDA approval for its use in the treatment of...
Guardado en:
Autores principales: | Alana MacDonald, T.-C. Wu, Chien-Fu Hung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb172ce1ca654f948f000f3fe9370909 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells
por: Alana MacDonald, et al.
Publicado: (2021) -
Duck Interleukin-22: Identification and Expression Analysis in Riemerella anatipestifer Infection
por: Rochelle A. Flores, et al.
Publicado: (2021) -
ROLE OF LECTIN-SUBSTRANCE RECOGNITION IN IMMUNOREGULATORY INTERACTION BETWEEN INTERLEUKIN-2 IGG
por: S. M. Sobolev, et al.
Publicado: (2014) -
Biologic treatments in Behçet’s disease
por: Fatma Alibaz-Öner, et al.
Publicado: (2021) -
INTERLEUKIN 33 AND FIBROSIS: PATHOGENESIS UPDATED
por: E. G. Uchasova, et al.
Publicado: (2018)